Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016
EV/FCFF
Enterprise Value to FCFF
Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.
Market Cap | EV/FCFF | ||||
---|---|---|---|---|---|
CN |
Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016
|
13.9B CNY | 23.5 | ||
CH |
Alcon AG
SIX:ALC
|
39.7B CHF | 61.4 | ||
JP |
Hoya Corp
TSE:7741
|
6.7T JPY | 36.7 | ||
DK |
Coloplast A/S
CSE:COLO B
|
185.4B DKK | 194.4 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
19.2B USD | 30.1 | ||
US |
Cooper Companies Inc
NYSE:COO
|
18.7B USD | 156.7 | ||
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
59.5B CNY | 49.6 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.1B GBP | 528.5 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.8B USD | 26.1 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
8T KRW | -61.7 | |
CH |
Ypsomed Holding AG
SIX:YPSN
|
5.2B CHF | -126.5 |
EV/FCFF Forward Multiples
Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.